TY - JOUR T1 - Evaluation of the sensitivity, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production JF - medRxiv DO - 10.1101/2021.04.21.21255874 SP - 2021.04.21.21255874 AU - Maria-Inti Metzendorf AU - Robin M. Featherstone Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/04/25/2021.04.21.21255874.abstract N2 - Introduction The Cochrane COVID-19 Study Register (CCSR) is a public, continually updated, curated database of COVID-19 study references. The aim of this study-based register is to support rapid and living evidence synthesis, including a project to build an evidence ecosystem of COVID-19 research (CEOsys). In November and December 2020 we conducted an evaluation of the CCSR for CEOsys, measured its performance and identified areas for improvement.Methods For the evaluation we generated a purposive sample of 286 studies from 20 reviews to calculate the CCSR’s sensitivity (comprehensiveness), accuracy (correctly classified and linked studies) and currency (time to publish and process references).Results The CCSR had an overall sensitivity of 77.2%, with the highest sensitivity for interventional studies (94.4%) and lowest sensitivity for modelling studies (63.6%). The study register had 100% sensitivity for trial registry records, 86.5% for journal articles and 52.4% for preprints. 98.3% of references were correctly classified with regard to study type, and 93.4% with regard to study aim. 89% of studies were correctly linked. 81.4% of references were published to the register in under 30 days, with 0.5 day (median) for trial registry records, 2 days for journal articles and 56 days for preprints.Conclusion The CCSR had high sensitivity, accurate study classifications and short publishing times for journal articles and trial registry records. We identified that the CCSR’s coverage and publishing times for preprints needed improvement. Finally, the evaluation illustrated the value of a study-based register for identifying additional study references for analysis in evidence synthesis.Competing Interest StatementMaria-Inti Metzendorf works as Information Specialist at the Cochrane Metabolic and Endocrine Disorders Group and is employed by the Heinrich-Heine University in Duesseldorf. Robin Featherstone is employed by Cochrane as Information Specialist in the Editorial and Methods Department. Both investigators are involved in the production of the Cochrane Covid-19 Study Register.Clinical Protocols https://osf.io/vrngd Funding StatementThis work was conducted within the CEOsys project (www.covid-evidenz.de), funded under a scheme issued by the Network of University Medicine (Nationales Forschungsnetzwerk der Universitaetsmedizin (NUM)) by the Federal Ministry of Education and Research of Germany (Bundesministerium fuer Bildung und Forschung (BMBF)), grant number 01KX2021.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This evaluation does not include patient data and does therefore not require IRB or ethics committee approval.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on OSF: https://osf.io/t3ycx/. https://osf.io/t3ycx/ ER -